Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated

被引：3

作者：

Ludwig, Heinz ^{[1
]}

Kasparu, Hedwig ^{[2
]}

Greil, Richard ^{[3
]}

Leitgeb, Clemens ^{[1
]}

Muelduer, Ercan ^{[1
]}

Rauch, Elisabeth ^{[1
]}

Zojer, Niklas ^{[1
]}

Autzinger, Eva Maria ^{[1
]}

Linkesch, Werner ^{[4
]}

Kuhr, Thomas ^{[5
]}

Pour, Ludek ^{[6
]}

Adam, Zdenek ^{[7
]}

机构：

[1] Wilhelminenhospital, Dept Internal Med 1, Ctr Oncol & Hematol, Vienna, Austria

[2] Hosp Elisabethinen, Dpt Internal Med, Linz, Austria

[3] Univ Hosp Salzburg, Dept Internal Med 3, Salzburg, Austria

[4] Med Univ Graz, Dept Hematol, Graz, Austria

[5] Klinikum Wels Grieskirchen, Dept Internal Med 4, Wels, Austria

[6] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[7] Univ Hosp Brno, Dept Internal Med Hematooncol, Brno, Czech Republic

来源：

关键词：

D O I：

10.1182/blood.V120.21.943.943

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

943

引用

页数：2